Company Encyclopedia
View More
name
HANXBIO-B
03378.HK
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China.
1.267 T
03378.HKMarket value -Rank by Market Cap -/-

Financial Score

25/12/2025 Update
D
BiotechnologyIndustry
Industry Ranking42/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-53.33%E
    • Profit Margin-5267.39%E
    • Gross Margin100.00%A
  • Growth ScoreE
    • Revenue YoY-14.63%E
    • Net Profit YoY-50.12%D
    • Total Assets YoY-17.28%E
    • Net Assets YoY-34.46%E
  • Cash ScoreD
    • Cash Flow Margin-1.90%D
    • OCF YoY-14.63%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreD
    • Gearing Ratio56.81%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --